Company
Pliant Therapeutics
Bringing hope through the discovery and development of integrin-based therapies in underserved areas of medical need
- Status
- Operatingas of 2026-09-18Source (opens in a new tab)
- Business model
- B2B
- Legal name
- Pliant Therapeutics
- pliantrx.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Pliant Therapeutics is a clinical-stage biopharmaceutical company and leader in the development of integrin-based therapeutics.
Funding snapshot
- Total raised
- $163MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $100M2019-12-19
Funding rounds
- Round, 2019
- $100M2019-12-19, SEC form D sold, 66 investors
- Round, 2018
- $62.1M2018-07-10, SEC form D sold, 29 investors
Products
- Other
- PLN-101095
Loading relationship preview